PerkinElmer Acquires C&A Service Solutions
News Jun 06, 2006
PerkinElmer, Inc. has announced the acquisition of Clinical & Analytical Service Solutions Ltd. (C&A), a scientific equipment asset and managed maintenance company serving the pharmaceutical, biotechnology and healthcare markets.
C&A will become an integral part of PerkinElmer's OneSource® service products within its Laboratory Services business.
The acquisition, which leverages the strengths of both companies, enhances PerkinElmer's ability to meet the needs of the estimated $2.5 billion laboratory equipment aftermarket, according to Robert F. Friel, president of PerkinElmer Life and Analytical Sciences.
"We continue to see our customers embrace the OneSource model, which enables them to realize significant cost savings through more focused management of maintenance expense and asset management, while ensuring maximum uptime for their laboratories," explained Friel.
"This strategic acquisition is a logical next step in our continued effort to help scientists keep their focus on their research results while we work on the operational front to maximize productivity, reduce costs and enhance compliance."
Under the OneSource umbrella, managed maintenance experts joining PerkinElmer from C&A will complement PerkinElmer's technical expertise on a broad spectrum of capabilities for a wide range of equipment platforms.
Through C&A's extensive databases of equipment maintenance solutions and performance histories, OneSource will offer customized managed maintenance solutions tailored to the requirements of each customer.
"This is a proven solution for cost reduction and increased service levels which can be used to consolidate the management of a wide portfolio of equipment models found in a typical laboratory environment into a single maintenance program," said Ken Caskie, managing director, C&A.
"Given today's management demands for lab performance, OneSource will provide alternative options with measurable results offering the best in asset managed maintenance and technical expertise to reduce costs, enhance management information and drive improved service delivery. A truly superior product offering can now be delivered to the market."
A new chemical synthesis strategy to harvest the rich information found in natural products has led to the identification of novel, simpler derivatives with potential to selectively protect neurons, important for neurodegenerative diseases like Alzheimer’s disease, or to prevent the body’s immune system from rejecting organ transplants, according to a Baylor University-led study.READ MORE